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Background: To assess pain or stress in newborn infants submitted to intensive care is important but difﬁcult,
as different observational pain scales are not always reliable in premature infants. As an indicator of pain, skin
conductance (SC) measurements have detected increased sweating in newborn infants N28 gestational age
(GA) submitted to heel lancing.
Objective: To measure SC during heel lancing and routine care in newborn infants, born at 22 to 27 GA, with
special relation to postnatal age (PNA).
Methods: In six infants b28+0 GA and 4 infants ≥28+0 GA spontaneous SC activity and behavioural state
(Neonatal Pain Agitation and Sedation Scale (N-PASS)) was measured before, during and after each
intervention. Measurements were repeated in each patient at different PNA.
Results: Baseline SC prior to intervention took longer time to stabilise and was higher in b28 than in ≥28+0
PNA. The combination of heel lancing and squeezing gave an increased SC in b28 PNA, whereas heel lancing
alone gave the same SC response in ≥28+0 PNA. A possibly continued immature response in SC
measurements was not observed. Oral glucose admission prior to heel lancing increased SC. Routine care did
not give any changes in SC. Except during orogastric tube placement no signs of discomfort or pain could be
detected by the neonatal pain, agitation and sedation scale (N-PASS) in b28 PNA.
Conclusion: Changes in SC could be detected in infants at b28+0 PNA and related to the combination of heel
lancing and squeezing. A maturational development of the SC was observed in infants born b28 GA. SC seems
to be able to differentiate between pain and discomfort.
© 2011 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
Extremely preterm infants are subjected to an intensive care that is
characterised by many painful procedures and environmental
disturbances. To assess pain or stress in newborn infants submitted
to intensive care is important in order to evaluate effective pain
management and thereby reduce harmful short and long term effects
of pain; speciﬁcally brain development [1]. Many studies have been
performed to assess pain in preterm infants, but it has been difﬁcult to
ﬁnd a “golden standard” to measure the pain or discomfort theymight
experience during potentially painful procedures in the intensive care
unit [1,2]. As both physiological and observational pain scores
developed for more mature infants have been shown to have theirce; PNA, postnatal age; N-PASS,
idermal water loss.
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develop new method for pain assessment [2–7].
Emotional sweating is a physical reaction to emotive stimuli like
stress, anxiety, fear and pain that can occur over thewhole body surface,
but is most evident on palms, soles and in the axillary region [8]. Unlike
thermoregulatory sweating, it arises independently of ambient tem-
perature and decreases during sleep and relaxation [8]. Emotional
sweating of palms and soles occurs already in newborn infants [9].
A sensitive method of measuring skin conductance (SC) has been
developed, based on stress induced sweating. SC is determined by the
number and the activity of sweat glands, and their activity is
stimulated by the sympathetic nervous system [10–14]. When pain
is experienced, sweat glands are stimulated by sympathetic excitatory
efferent neurons and sweat is released within 1–2 s whereby SC
increases due to skin resistance reduction [10,15]. When the painful
stimulus is taken away, sympathetic activity decreases and the sweat
is reabsorbed and evaporated, followed by a decrease in skin
conductance. The sympathetic neural ﬁring resulting in excretion of
the sweat gland can be depicted as one skin conductance peak [10,16].
The number of skin conductance peaks correlates directly to the ﬁring
rate in the sympathetic nerves of the skin [17]. Previous studies in
Fig. 1. Application of skin conductance measurement electrodes on the foot of a 26 PNA
weeks infant.
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with the level of behavioural state [18]. To our knowledge no SC
studies have been performed in premature infants born at b28 GA.
The aim of this study was to ﬁnd out at which GA preterm
newborn infants start to react to potential painful or discomforting
procedures by emotional sweating and how this response changes
with different PNA.
2. Methods
2.1. General
The study was performed at the neonatal care unit, Uppsala
University Children's Hospital in Uppsala, Sweden. SC was measured
when infants were exposed to heel lancing for routine blood sampling,
feeding, orogastric tube placement and routine care. Observing the
infants with N-PASS, an observational scale used as routine assessment
of pain in this neonatal unit, included behavioural changes associated
with pain perception [19].
2.2. Patients
Ten preterm infants were recruited from the neonatal care unit,
Uppsala University Children's Hospital during a period of 3 months.
Infants who were in a haemodynamically stable condition and did not
receive any anaesthetics that might have interfered with their pain
response to planned clinically indicated heel lancing were eligible for
participation. No patients recruited were excluded.
In total there were six girls and four boys. The infants were born
between 22+4 and 34+3 weeks (median: 28+1 weeks) GA and at
the time of the study they were between 1 and 47 days PNA (median:
15 days).
Patients were divided into 2 groups: b28 weeks GA and N28 weeks
GA. These two groups were analysed in four different ways:
b28 weeks GA, N28 weeks GA, b28 weeks PNA and N28 weeks PNA.
Median weight at birth was 633 g (range: 437 g–920 g) b28 weeks
GA and 2191 g (range: 1727 g–2910 g) ≥28 weeks GA. At the time of
participation in the study themedianweight b28 weeks PNAwas 548 g
(range: 522 g–580 g).MeanAPGAR-scoreswere 4, 6 and 8 (respectively
after 1, 5 and 10 min) in infants b28 weeks, and 7, 9 and 9 in infants
N28 weeks.
All the patients b28 weeks GA were artiﬁcially ventilated. None of
the patients N28 weeks GA needed respiratory assistance. The study
was approved by the Ethics Committee of the Medical Faculty at
Uppsala University. Parental consent was obtained before the infant
was included in the study and reconﬁrmed before each subsequent
measurement.
2.3. Methods and measurements
In this longitudinal cohort study SC was measured with the Med-
Storm Pain Monitor (Medstorm Innovations, Oslo, Norway) [9]. Three
electrodes were applied on the infant's foot and measurements of SC,
number of ﬂuctuations within the mean SC per second (NFSC) and
amplitude of NFSC were analysed. The counter current electrode was
placed on themedial right side of the foot, themeasuring electrode was
placed midway between the ﬁrst phalanx and a point directly beneath
the ankle and the reference voltage electrode was placed on the dorsal
sideof the foot (Fig. 1). The analysed values are peaks/s (the rate ofﬁring
in the sympathetic nerves), average amplitude (mean peaks) and area
under curve (forcefulness of sympathetic nerve ﬁring). The N-PASSwas
used to analyse behavioural state, irritability, facial expression, tone and
vital signs in preterm infants, and performed simultaneously by a care
giving nurse and the researcher [19]. The N-PASS was speciﬁcally
chosen as an observational assessment tool because it is the most
commonly used tool in our neonatal ward. Transepidermal water loss(TEWL) was measured in three patients at b28 weeks GA in order to
deﬁne the maturational status of the skin, a factor that might interfere
with the emotional sweating [20].
Heart rate and saturation were measured in patients b28 GA and
PNA before, during and after each registration period.
2.4. Study design
Measurements were performed during heel lancing for routine
blood collection and during feeding, orogastric tube placement and
routine care such as diaper change, feeding and auscultation.
Electrodes were applied to the infants' foot 5 min before the
intervention.
All heel lancing was scheduled at least 1 h after feeding. All infants
received 0.5 ml 30% oral glucose before heel lancing according to
established unit policy, except for one extremely preterm boy with
insulin infusion due to hyperglycaemia. Behavioural state (N-PASS)
and skin conductance activity were measured for 2 min before,
during, and for 2 min after the intervention.
During heel lance electrodes were attached to the opposite foot to
prevent any artefacts by touching the measurement electrode.
Measurements started at least 1 min before the glucose was given.
After the heel lance and the squeezing period the measurement
continued for at least 2 min.
Orogastric tube placement was performed within a minute.
Measurement of SC and of N-PASS continued for a couple of minutes.
Feeding was done with a syringe and in very small portions, during at
least ﬁve and at most 30 min. After feeding the measurement
continued for at least 3 min.
Skin conductance registrations were made for approximately
10 min. Auscultation with a stethoscope was also measured, as was
the effect of tactile stimuli (such as caressing the child and kangaroo
mother care), sounds (in the ward) andwarm versus cold (water bags
on the infants' feet before heel lancing and application of a cold
stethoscope).
The groupswere analysed in four different ways: b28 weeks GA and
N28 weeks GA independent of PNA; b28 PNA and N28 weeks PNA
independent of GA. Themeans for each analysiswere put into tables and
ﬁgures.
2.5. Method of analysis
Measurements of SCwere analysed by taking thirty-second intervals
of which themeanpeaks/s and average peakwere calculated. The thirty
23J. Munsters et al. / Early Human Development 88 (2012) 21–26second time intervals were chosen because the time between glucose
given prior to heel lancing and the start of heel lancing was
approximately 30 s and thereby enabling comparisons of all registered
intervals. The ﬁrst baseline was deﬁned as the thirty-second interval
before glucose administration. For the heel lancing one period of thirty
seconds was taken, because right after the heel lance the nurses began
squeezing the foot. The second baseline was deﬁned as the interval
where the peaks/s and the average peak lowered signiﬁcantly or
returned to zero.
2.6. Statistics
Repeated-measures analysis of variance was used to test for
differences between measurements made during the various interven-
tions studied. Student's t-test for two-sided paired observations was
appliedwhenever a differencewas detected by analysis of variance, and
differences were considered signiﬁcant at pb0.05.
3. Results
All infants b28 weeks GA (n=6) were on theophylline and infants
N28 weeks GA (n=4) were not on any medication at the time of
measurements (Table 1). Baseline SC prior to intervention took longer
time to stabilise – approximately 5 min – andwas higher in b28 than in
≥28+0 PNA (0.07±0.03 peaks/s vs. 0.01±0.01 peaks/s: p=0.037).
Irrespective of the duration of the heel lancing procedure, the skin
conductance after painful stimuli also took a longer time to return to
baseline levels inb28 than in≥28+0 weeksPNA(123±16vs. 21±9s;
pb0.0001).
The combined heel lancing and squeezing gave an increased SC in
b28 PNA (Fig. 3B), whereas heel lancing alone gave the same SC
response in ≥28+0 PNA, which was maintained at the same level
during squeezing (Figs. 2 and 3D). A possibly continued immature
response to heel lancing and/or squeezing irrespective of PNA was
not observed, as SC responses related to only GA was similar between
b28+0 and ≥28+0 weeks GA (Figs. 2, 3A and C). All infants tended
to have an increased SC to glucose administration prior to heel
lancing: in b28 PNA at the same level as maximal SC but in ≥28+0
PNA lower than heel lancing and squeezing (Fig. 3B and D). Other
interventions, such as tactile stimuli, orogastric tube placement,
feeding, cold or warm stethoscope application did not result in any
changes in SC.Table 1
Demographic characteristics of the population studied.
Characteristics Results
b28 GA ≥28 GA
Number of patients (n) 6 4
GA (weeks) 24+4±1+5
[22+4–26+6]
33+2±1+1
[33+0–34+3]
PNA (days) 21±13 [3–47] 6±5 (1–16)
Birth weight (grammes) 633 g.±179
(437–920)
2191 g.±529
(1727–2910)
Apgar scores
1 min 4±1.75 (2–7) 8±0.8 (7–9)
5 min 7±2.25 (4–9) 9±0.95 (8–10)
10 min 8±1.26 (6–9) 9±0.96 (8–10)
Intraventricular haemorrhage (grade I–IV) 0 IV+I/II (n=1)
Patent ductus arteriosus 6 0
Indomethacin 3 0
Operation 3 0
Medication
Surfactant 6 0
Theofyllin 6 1
Vitamin A, D, C 1 0
Antibiotics 0 0
Saline substitution 5 0The N-PASS was used as an observational scale to compare with
the SC results. No signs of discomfort or pain could be detected with
N-PASS in infants born at b28 GA during glucose administration, heel
lancing with squeezing or routine care, except during orogastric tube
placement. Even though the infants were in discomfort during
orogastric tube placement, according to N-PASS (Table 2), no changes
in SC were detected during this intervention.
Baseline heart rate did not vary signiﬁcantly between patients but
increased during the heel lancing procedure by more than 10 bpm.
Saturation varied widely and sometimes went below 80% during
intervention. Both heart rates and saturation levels returned to
baseline soon after the heel lancing procedure was stopped.
4. Discussion
This study shows that a stress response to heel lancing can be
detected with skin conductance measurements from 22 weeks GA.
Baseline levels of skin conductance prior to stimuli were higher in
infants b28 weeks PNA than in infants ≥28 weeks PNA. One
explanation could be the maturational aspect of the skin. The
permeability of the skin gradually changes with GA and PNA as
trans-epidermal water loss (TEWL) decreases in preterm infants
during their ﬁrst weeks of life [20,21]. However, TEWL does not cause
bursts of excretion and the TEWL measurements in our study of
infants b28 weeks PNA were constant and stable, and not related to
pain evoked changes in skin conductance. Although measures were
taken to exclude environmental disturbances during measurements
of heel lancing and planned interventions, a higher state of stress
cannot be excluded as a reason for the observed higher baseline level
of skin conductance in our cohort of infants born b28 weeks GA and at
≥28 weeks PNA, as these infants might have been exposed to more
painful procedures as part of their intensive care with possibly
adverse effects on their immediate pain response [22–25]. On the
other hand, a long-term effect on the pain response of b28 weeks GA
is not fully consistent with the fact that their response to heel lancing
with skin conductancemeasurements at N28 weeks PNA did not differ
from infants born ≥28 weeks GA (see Fig. 3C and D), also supported
by follow up studies on recovered biobehavioral responses to acute
pain in former extremely low birth weight infants [26].
A prolonged pain response after heel lancing could be due to an
immature sympathetic regulation or cortical pain processing, as
shown in studies of preterm infants born after 25 GA where increases
in cortical total haemoglobin concentrations after heel lancing were
used as a measure of pain response and where maturational dif-
ferences were detected [27,28]. Interestingly, Slater et al. propose a
difference between spinal and cortical pain processing based on the
fact that the amplitude and the duration of pain response is markedly
higher for peripheral than central pathways in more immature
infants, and that peripheral pathways do not necessarily imply a
perceived pain [28–30]. Maturational similarities in both duration and
amplitude between our skin conductance measurements and spinal
pain processing seem to exist, but both the higher baseline activity
prior to stimuli and the markedly lower baseline after stimuli indicates
yet another pain response, further supported by the difference in SC
response topotentially painful stimuli, i.e. heel lancing, and squeezing in
the present study.
Infants b28 weeks PNA seemed to react more to the squeezing
after the heel lancing, whereas the more mature infants reacted more
strongly to the actual heel lancing procedure. A previously published
study interpreted latency in facial response to heel lancing in
newborn infants below 32 weeks PNA to be caused by less myelina-
tion and slower neurotransmission in immature subjects [31], an
explanation feasible with the delayed response in our study to heel
lancing in infants below 28 weeks PNA and consequently the over-
lapping of heel lancing and squeezing. However, the threshold for
mechanical stimulation, as studied by ﬂexion withdrawal reﬂex, has
Fig. 2. Skin conductance registration (μS) in one infant b28 weeks GA at ≥27 PNA, with each intervention (⁎1–4) depicted over time (hh.mm.ss = hours.minutes.seconds).
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Fig. 3. (A) Skin conductance response to heel lancing in newborn infants b28 weeks GA. Error bars denoting standard error of mean. ⁎p=0.036 baseline 2 vs. heel lancing. (B) Skin
conductance response to heel lancing in newborn infants b28 weeks PNA. Note the markedly lower baseline (baseline 2) after heel lancing and squeezing than prior (baseline 1) to
heel lancing and squeezing. Error bars denoting standard error of mean. ⁎p=0.039 baseline 2 vs. baseline 1. (C) Skin conductance response (peaks/s) to heel lancing in newborn
infants≥28 weeks GA. Error bars denoting standard error of mean. ⁎p=0.052 glucose vs. heel lancing; #p=0.073 glucose vs. squeezing. (D) Skin conductance response (peaks/s) to
heel lancing in newborn infants ≥28 weeks PNA. Note the markedly increased response of peaks/sec during heel lancing and squeezing. Error bars denoting standard error of mean.
⁎p=0.019 glucose vs. heel lancing; #p=0.029 glucose vs. squeezing; §p=0.044 glucose vs. baseline 1.
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Table 2
Mean N-PASS results b28 weeks PNA.
Assessment criteria Mean scoreb28 PNA
Crying irritability No cry with painful stimuli (−2)
Behavioural state Arouses minimally to stimuli, little spontaneous
movement (−1)
Facial expression Mouth is lax, no expression (−2)
Extremities tone Weak grasp reﬂex, ↓ muscle tone (−1)
Vital signs (HR/BP/SaO2) b10% variability from baseline with stimuli (−1)
Premature pain assessment: +3 if b28 weeks gestation/corrected age.
25J. Munsters et al. / Early Human Development 88 (2012) 21–26been shown to be lower in preterm infants [32,33] and therefore a
postponed response to heel lancing cannot be excluded from our data.
Squeezing was not separated from the heel lancing procedure in the
present study since there was no ethical disclosure for measuring SC
during squeezing alone. Nevertheless, some of the normal care
procedures of these infants included moderate pressure of the skin
during SC measurements and these did not evoke an increase in SC.
All infants tended to respond with increased SC to oral glucose as
related to baseline irrespective of GA or PNA (Fig. 3A–D). As this was
an unanticipated ﬁnding, SC measurements for oral glucose are
presented separately in all ﬁgures. Several randomised clinical trials
have shown that oral sucrose reduces the behavioural pain response
to subsequent routine care giving procedures as assessed by
observational pain scales [34–36]. Since it was not our intention to
challenge this view, neither a comparisonwith other oral agents, or an
evaluation of the effectiveness of oral glucose on SC measurements
weremade. However, the effectiveness of sucrose as an analgesic drug
has been questioned in studies where sucrose had no effect on spinal
or cortical pain responses [37,38]. In our study no signiﬁcant
behavioural pain responses were observed during glucose adminis-
tration (or heel lancing) although SC responses to glucose were
detected, especially in infants ≥28 PNA weeks (Fig. 3D).
Behavioural state measured by the N-PASS was not a sufﬁcient tool
to compare the changes in SC measurements. Because of ventilatory
support, orogastric and nasal tubes, it is difﬁcult to observe discrete
changes in facial expression as previously noted and nor can crying be
observed in ventilated infants [39]. The N-PASS does correct for
prematurity by adding three points in advance for inability to cry, little
to no spontaneousmovement and lowmuscle tone, but still it is difﬁcult
to interpret the results of this scale in extremely preterm infants. Future
SC research should compare SCwith other pain assessment tools suchas
cardiovascular response [40], near-infrared spectroscopy (NIRS) [27],
withdrawal reﬂex [32], salivary cortisol [41] and EEG [42].
Although the limitation of this study is the small sample size,
repeated measurements always showed a SC response related to heel
lancing and squeezing, but not related to other stimuli included in the
normal care of newborn infants. Other potentially stressful procedures
should be studied in the future in combination with pain relieving
interventions.
Evaluating stress response to painful stimuli in preterm infants
might assist clinicians to provide the most effective pain management
strategies, and thereby prevent the negative short and long term
effects of pain [22,43–45]. Monitoring skin conductance may be a
useful tool to do so. Nevertheless, artefacts are likely to occur, when
infants move or electrodes become detached from the skin.
Interference with other electrical monitoring such as EEG and ECG
should also be excluded. Therefore it is important to observe the
infants continuously in order to get a reliable SC measurement.
In conclusion, measurements of SC activity showed responses to
heel lancing in preterm infants between 22 and 27 weeks GA with a
maturational development related to PNA.
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